DE69426655D1 - Hiv-protease inhibitoren und zwischenprodukte - Google Patents

Hiv-protease inhibitoren und zwischenprodukte

Info

Publication number
DE69426655D1
DE69426655D1 DE69426655T DE69426655T DE69426655D1 DE 69426655 D1 DE69426655 D1 DE 69426655D1 DE 69426655 T DE69426655 T DE 69426655T DE 69426655 T DE69426655 T DE 69426655T DE 69426655 D1 DE69426655 D1 DE 69426655D1
Authority
DE
Germany
Prior art keywords
hiv protease
protease inhibitors
intermediate products
hiv
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69426655T
Other languages
English (en)
Other versions
DE69426655T2 (de
Inventor
Joseph Hornback
Edwin Munroe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69426655D1 publication Critical patent/DE69426655D1/de
Publication of DE69426655T2 publication Critical patent/DE69426655T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69426655T 1994-02-02 1994-10-06 Hiv-protease inhibitoren und zwischenprodukte Expired - Fee Related DE69426655T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19080994A 1994-02-02 1994-02-02
PCT/US1994/011361 WO1995020965A1 (en) 1994-02-02 1994-10-06 Hiv protease inhibitors and intermediates

Publications (2)

Publication Number Publication Date
DE69426655D1 true DE69426655D1 (de) 2001-03-08
DE69426655T2 DE69426655T2 (de) 2001-06-13

Family

ID=22702879

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69426655T Expired - Fee Related DE69426655T2 (de) 1994-02-02 1994-10-06 Hiv-protease inhibitoren und zwischenprodukte

Country Status (14)

Country Link
US (1) US5734057A (de)
EP (1) EP0746320B1 (de)
JP (1) JPH09508416A (de)
AT (1) ATE198985T1 (de)
AU (1) AU8074894A (de)
BR (1) BR9408531A (de)
CA (1) CA2182090A1 (de)
DE (1) DE69426655T2 (de)
DK (1) DK0746320T3 (de)
ES (1) ES2153434T3 (de)
GR (1) GR3035716T3 (de)
HU (1) HUT74685A (de)
PT (1) PT746320E (de)
WO (1) WO1995020965A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5480887A (en) * 1994-02-02 1996-01-02 Eli Lilly And Company Protease inhibitors
AU2006269374C1 (en) * 2005-07-12 2010-03-25 Massachusetts Institute Of Technology Wireless non-radiative energy transfer
WO2012088266A2 (en) 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
CN107652289B (zh) 2012-06-13 2020-07-21 因塞特控股公司 作为fgfr抑制剂的取代的三环化合物
WO2014026125A1 (en) 2012-08-10 2014-02-13 Incyte Corporation Pyrazine derivatives as fgfr inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
JP6449244B2 (ja) 2013-04-19 2019-01-09 インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ Ｆｇｆｒ抑制剤としての二環式複素環
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
WO2016134320A1 (en) 2015-02-20 2016-08-25 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
SG11202010882XA (en) 2018-05-04 2020-11-27 Incyte Corp Salts of an fgfr inhibitor
DK3788047T3 (da) 2018-05-04 2024-09-16 Incyte Corp Faste former af en FGFR-inhibitor og fremgangsmåder til fremstilling deraf
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
WO2021007269A1 (en) 2019-07-09 2021-01-14 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
MX2022004513A (es) 2019-10-14 2022-07-19 Incyte Corp Heterociclos biciclicos como inhibidores de los receptores del factor de crecimiento de fibroblastos (fgfr).
WO2021076728A1 (en) 2019-10-16 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
BR112022010664A2 (pt) 2019-12-04 2022-08-16 Incyte Corp Derivados de um inibidor de fgfr
JP2023505258A (ja) 2019-12-04 2023-02-08 インサイト・コーポレイション Ｆｇｆｒ阻害剤としての三環式複素環
US12012409B2 (en) 2020-01-15 2024-06-18 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
EP4323405A1 (de) 2021-04-12 2024-02-21 Incyte Corporation Kombinationstherapie mit einem fgfr-inhibitor und einem auf nectin-4 abzielenden mittel
CA3220274A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2395271A1 (fr) * 1977-06-21 1979-01-19 Parcor Procede de preparation de thieno (2,3-c) et thieno (3,2-c) pyridines
US4749692A (en) * 1977-06-22 1988-06-07 Sanofi, S.A. Therapeutic compositions having anti-thrombotic and anti-blood-platelet-aggregating activity
FR2397417A1 (fr) * 1977-07-12 1979-02-09 Parcor Procede de preparation de derives de la thienopyridine
US5142056A (en) * 1989-05-23 1992-08-25 Abbott Laboratories Retroviral protease inhibiting compounds
IL89900A0 (en) * 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
EP0361341A3 (de) * 1988-09-28 1991-07-03 Miles Inc. Therapeutika für AIDS auf der Basis von HIV-Protease-Inhibitoren
US5026700A (en) * 1989-05-16 1991-06-25 Merrell Dow Pharmaceuticals Certain quinolines and thienopyridines as excitatory amino acid antagonists
US5232928A (en) * 1989-07-25 1993-08-03 Boehringer Ingelheim Pharmaceuticals, Inc. Tetrahydroisoquinoline amides
GB8927913D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Amino acid derivatives
EP0558603B1 (de) * 1990-11-19 1998-08-26 Monsanto Company Retrovirale protease inhibitoren
AU647239B2 (en) * 1991-02-08 1994-03-17 Sankyo Company Limited New beta-amino- alpha-hydroxycarboxylic acids and their use
WO1993008184A1 (en) * 1991-10-23 1993-04-29 Merck & Co., Inc. Hiv protease inhibitors
WO1993013066A1 (en) * 1991-12-20 1993-07-08 Syntex (U.S.A.) Inc. Cyclic amides of 3-amino-2-hydroxy-carboxylic acids as hiv-protease inhibitors
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US5480887A (en) * 1994-02-02 1996-01-02 Eli Lilly And Company Protease inhibitors

Also Published As

Publication number Publication date
BR9408531A (pt) 1997-08-05
EP0746320B1 (de) 2001-01-31
CA2182090A1 (en) 1995-08-10
DK0746320T3 (da) 2001-02-19
PT746320E (pt) 2001-05-31
AU8074894A (en) 1995-08-21
WO1995020965A1 (en) 1995-08-10
DE69426655T2 (de) 2001-06-13
US5734057A (en) 1998-03-31
EP0746320A1 (de) 1996-12-11
ES2153434T3 (es) 2001-03-01
HUT74685A (en) 1997-01-28
ATE198985T1 (de) 2001-02-15
GR3035716T3 (en) 2001-07-31
HU9602106D0 (en) 1996-09-30
JPH09508416A (ja) 1997-08-26
EP0746320A4 (de) 1997-06-11

Similar Documents

Publication Publication Date Title
ATE198985T1 (de) Hiv-protease inhibitoren und zwischenprodukte
NO893400L (no) Hiv protease inhibitorer egnet for behandling av aids.
MD1507G2 (ro) Inhibitori, compoziţie farmaceutică pe baza lor şi procedeu de inhibare a HIV proteazei
NO905428D0 (no) Fremgangsmaate for fremstilling av hiv-proteaseinhibitorerfor behandling av aids.
ES2139195T3 (es) Derivados de sulfonamidas como inhibidores de la aspartil-proteasa.
NO932620L (no) Amindiol-proteaseinhibitorer
PT810209E (pt) Hidroxietilamino-sulfonamidas de alfa- e beta-aminoacidos uteis como inibidores de protease retroviral
ES2051641A1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
NO954427D0 (no) Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS
PT1042305E (pt) Inibicao de quinase p38 utilizando difenilureias simetricas e assimetricas
MX9700237A (es) Combinaciones inhibidoras de proteasa retroviral.
ES2059293T3 (es) Inhibidores de proteasas retrovirales.
DK0804410T3 (da) Fremgangsmåde til fremstilling af retrovirale proteaseinhibitor-mellemprodukter
MY132553A (en) Methods of making hiv-protease inhibitors and intermediates for making hiv-protease inhibitors
NO934721D0 (no) Hemmere av HIV-protease som er nyttige for behandling av AIDS
BR9808923B1 (pt) processos para fazer compostos inibidores de ciclooxigenase-2, e, compostos intermediÁrios para fazer inibidores de ciclooxigenase-2.
EE9700165A (et) Ühendite kombinatsioon, meetod ja farmatseutiline kompositsioon HIV proteaasi ja HIV pöördtranskriptaasi inhibeerimiseks ning HIV infektsiooni vältimiseks või raviks, või AIDS-i või ARC raviks
NO982151D0 (no) Hemoregulatoriske forbindelser
WO2003068929A3 (en) Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors
EA199900257A1 (ru) Промежуточные соединения для получения ингибиторов вич-протеазы и способы получения ингибиторов вич-протеазы
NO168352C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-allen-alfa-amino-syrer

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee